April 02, 2026

USDA Alerts on Lead in Walmart Chicken Nuggets

Detected lead could be up to five times FDA’s interim reference level for children

Conexiant

April 01, 2026

Case Report Shows Carbimazole's ‘Triple-Hit’

Diffuse alveolar hemorrhage with coexistent antiphospholipid syndrome complicated anticoagulation therapy and created competing bleeding and thrombosis risks.

Conexiant

April 01, 2026

Visual Snow Challenges Diagnosis

A case highlights persistent visual symptoms despite normal testing and suggests a neurofunctional origin.

Conexiant

March 31, 2026

Meat Intake, APOE Status Linked to Cognitive Aging

Long-term cohort data suggest genotype-specific associations with cognition, not dementia interaction

Conexiant

March 31, 2026

Postzoster Neuralgia Linked to Tinnitus

Nationwide cohort analysis finds higher tinnitus incidence during long-term follow-up among patients with postzoster neuralgia, particularly older patients and certain comorbidities.

Conexiant

March 31, 2026

FDA Monthly Preview: Key April Decisions to Watch

Several high-stakes FDA decisions across multiple specialties are expected this month.

Conexiant

March 30, 2026

Side Effects: Variety Is Overrated

The organ you forgot, the cells that age unevenly, the AI that admits ignorance, and the diet advice that sounds wrong but isn't: medicine's next moves are hiding in plain sight.

Conexiant

March 30, 2026

A Two-Biomarker Signal for Alzheimer’s Disease

Dual plasma biomarkers may improve identification of established Alzheimer’s disease and signal faster decline

Conexiant

March 30, 2026

Surgical Approaches Evolve in Tremor Syndromes

Evidence review highlights expanding role of neuromodulation and lesioning, with differences across tremor types

Conexiant

March 30, 2026

Reducing Constipation in Parkinson’s, Step by Step

A 3-month walking program was associated with improved constipation symptoms and lower Parkinson’s disease severity scores in a small uncontrolled pre–post study

Conexiant